MENU
DCOY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Decoy Therapeutics (DCOY) Ownership - Who owns Decoy Therapeutics?

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform... Show more

Profile

Industry
N/A
Address
2450 Holcombe Boulevard
Phone
+1 713 913-5608
Employees
11
Web
https://www.decoytx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
701.05K
P/E Ratio
0.01
Total Cash
8.29M
Projected Growth
N/A
Total Debt
112.23K
Revenue
N/A
Risk (Beta)
1.26
Dividend Yield
N/A
Total Cash/Share
12.65
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Decoy Therapeutics? DCOY symbol Ownership - Tickeron.com